biosurfit renewed the CE marking for the spinit® CRP with improved performance. With the updated system, the spinit® is able to quantify the CRP in an extended range and with improved precision. Furthermore, the spinit® uses advanced an internal Quality Control system with positive and negative controls for enhanced performance.


About biosurfit
biosurfit is a Venture Capital backed diagnostics company founded in 2006. The company invented and developed breakthrough technologies that enable fast, precise and affordable blood analysis, aiming for the key parameters that doctors really want. These proprietary technologies are combined in the spinit® instrument, using a user-friendly reader and disposable disk cartridges for specific clinical conditions. The spinit® instrument uses only one drop of blood to deliver precise results within 10-15 minutes. Initial disposable cartridges to be launched in 2013 include CRP, Blood Count and an Inflammation Panel. It is planned that future tests will include diabetes and cardiac multi-parameter panels.

For more information, please contact:

Daniel Neves, CMO of biosurfit, tel: +351 217500228